Corxel US to go public via SPAC merger with Amanat Acquisition Corp
Corxel Pharmaceuticals, a clinical-stage obesity biopharma, announced a definitive business combination agreement with Amanat Acquisition Corp (Nasdaq: SLIM) to become a publicly listed company. The deal would create a publicly traded obesity-focused biopharmaceutical company, per Globe Newswire.
Source:
globenewswire.com: https://www.globenewswire.com/news-release/2026/10/26/3387902/0/en/corxel-us-and-amanat-acquisition-corp-announce-definitive-business-combination-agreement-to-create-publicly-listed-obesity-focused-biopharmaceutical-company.html
Not financial advice. For informational and educational purposes only.

